Trial Profile
The Efficacy and Safety of Carrimycin Treatment in Patients With Novel Coronavirus Infectious Disease (COVID-19) : A Multicenter, Randomized, Open-controlled Study
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2022
Price :
$35
*
At a glance
- Drugs Carrimycin (Primary) ; Chloroquine; Lopinavir/ritonavir; Umifenovir
- Indications COVID 2019 infections; Pneumonia; Respiratory distress syndrome
- Focus Therapeutic Use
- 06 Mar 2020 New trial record